HEALTH OF WOMAN. 2019.1(137):110–112; doi 10.15574/HW.2019.137.110

Kosilova S. Y.
HSSI «Bukovinian state medical University», Chernivtsi

Postmenopausal period is characterized not only by vasomotor signs and emotional-psychic maladjustment but the development of urogenital disorders and atrophic vaginitis caused by estrogen deficiency. Contrary to other menopausal symptoms the signs of vaginal atrophy in the majority of patients is of a progressing character deteriorating the quality of life and requiring pharmacological correction. 

Clinical-laboratory examination of 50 women suffering from atrophic vaginitis was carried out. The women were divided into 2 groups. The first group of patients was treated with local substitution hormonal therapy (SHT) for atrophic vaginitis, and the second one – in addition to SHT received intravaginal medicine containing glycogen and lactic acid for both therapeutic and preventive purposes. The results of the study showed that women from the first group developed a relapse of atrophic vaginitis with the lapse of time, and microbiocenosis of the vagina was disturbed. More stable clinical effect (88%) was achieved in patients of the second group. Atrophic vaginitis did not develop and vaginal microbiocenosis was not disturbed, which is a measure to prevent relapses of this pathology. 

Key words: postmenopause, atrophic vaginitis, vaginal microbiocenosis.

REFERENCES

1. Aylamazyan EK. (2013). Ginekologiya ot pubertata do postmenapauzyi: 487. M.

2. Dubossarskaya ZM, Goncharenko VN, Dubossarskaya YuA. (2012). Mikrobiotsenoz pri urogenitalnyih rasstroystvah u zhenshin v postmenopauze. Zb. nauk. prats Asots. akush.-gIn. UkraYini: 229–233. K.

3. Kyshakevych IT, Konar RS. (2016). Korektsiia dysmetabolichnykh proiaviv u zhinok v perymenopauzi ta rannomu menopauzalnomu periodi na foni fibrozno-kistoznoi mastopatii. Reproduktyvna endokrynolohiia 4: 82–86. K.

4. Kempbell S, Mong E. (2013). Ginekologiya ot desyati uchiteley. M, MIA: 328.

5. Natsionalnyi konsensus shchodo vedennia patsiientok u klimakterii. (2016). Reproduktyvnaia еndokrynologiya 1 (27): 8–25.

6. Zaporozhan VM, Bespoiasna VV, Yermolenko TO, Lavrynenko HL. Pat. 63195 A Ukraina, MPK A61K 38/27, A61K 35/74. Sposib likuvannia atrofichnoho vahinitu u zhinok v postmenopauzalnomu periodi. Zaiavnyk Odeskyi derzhavnyi medychnyi universytet. – zaiav. No. 2003021617 vid 24.02.2003. opubl. 15.01.2004, biul. № 1.

7. Tatarchuk TF, Efimenko OA, Islamova AO. (2013). Menopauza: novyiy vzglyad na staruyu problemu. Reproduktivnaya endokrinologiya 1.

8. Genri M Kronberg, Shlomo Melmed, Tenet S Polonski, Rid Larsen P. (2011). Endokrinologiya po Vilyamsu. Reproduktivnaya endokrinologiya: 410.

9. Black DM, Steinbuch M, Palermo L et al. (2011). An assessment toot for predicting fracture risk in postmenopausal women. Osteoporos Int 12:519-28. https://doi.org/10.1007/s001980170072; PMid:11527048